Followers | 43 |
Posts | 5751 |
Boards Moderated | 0 |
Alias Born | 04/12/2021 |
Monday, June 27, 2022 5:41:56 AM
“
On July 28, 2021, the Company filed a certificate of change to the Company’s amended and restated certificate of incorporation, with the Secretary of State of the State of Nevada to effectuate a one-for-two (1:2) reverse stock split (the “Reverse Stock Split”) of the Company’s common stock. Proportional adjustments for the Reverse Stock Split were made to the Company’s outstanding stock options, warrants and equity incentive plans. All share and per-share data and amounts have been retroactively adjusted as of the earliest period presented in the unaudited condensed financial statements to reflect the Reverse Stock Split.
Basis of presentation and liquidity
As reflected in the accompanying condensed financial statements, for the three months ended March 31, 2022 and 2021, the Company incurred a net loss of $3,365,846 and $996,771, respectively. Additionally, for the three months ended March 31, 2022 and 2021, the Company used cash in operations of $2,230,851 and $650,231, respectively. On March 31, 2022, the Company has an accumulated deficit of $30,956,392 and has generated minimal revenues since inception” - From most recent Quarterly report
my posts are always theory and not financial advice
Recent DATS News
- DatChat to Participate in Upcoming EF Hutton Annual Global Conference on May 15th in New York City • GlobeNewswire Inc. • 05/01/2024 12:47:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/29/2024 09:37:59 PM
- DatChat Unleashes AI Dog Racing and Full Monetization in Habytat Metaverse Expansion • GlobeNewswire Inc. • 02/29/2024 01:47:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 09:21:45 PM
- DatChat, Inc. Announces Closing of $1.8 Million Underwritten Public Offering of Common Stock • GlobeNewswire Inc. • 01/19/2024 09:05:00 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 01/18/2024 07:13:57 PM
- DatChat, Inc. Announces Pricing of $1.8 Million Underwritten Public Offering of Common Stock • GlobeNewswire Inc. • 01/17/2024 01:00:00 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 01/16/2024 09:53:58 PM
- DatChat, Inc. Announces Proposed Underwritten Public Offering of Common Stock • GlobeNewswire Inc. • 01/16/2024 09:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/16/2024 06:21:37 PM
- DatChat Issues Shareholder Letter and Provides Corporate Update • GlobeNewswire Inc. • 01/16/2024 03:30:00 PM
- DatChat Announces Planned Spin-off of its Habytat Platform Business into a New Standalone Public Company • GlobeNewswire Inc. • 01/16/2024 02:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/28/2023 09:30:25 PM
- DatChat Unveils the “Habytat” AI Social Gaming & Developer Platform • GlobeNewswire Inc. • 12/28/2023 01:47:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 09:35:58 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 11/09/2023 09:03:03 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 11/09/2023 09:01:52 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/09/2023 09:01:19 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 10/27/2023 08:30:39 PM
- DatChat Receives Notice of Allowance for its Patent Application "Technology Platform for Providing Secure Group-Based Digital Access to Sets of Digital Assets" • GlobeNewswire Inc. • 10/18/2023 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/10/2023 12:07:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/19/2023 08:10:39 PM
- CORRECTING and REPLACING DatChat Announces a 1:10 Reverse Stock Split Effective at the Open of Trading on September 20, 2023 • Business Wire • 09/19/2023 02:25:00 PM
- DatChat Announces a 1:10 Reverse Stock Split Effective at the Open of Trading on September 19, 2023 • Business Wire • 09/19/2023 12:30:00 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM